Final invoice issued by EarlyBirdCapital, Inc. to Moringa Acquisition Corp under the Business Combination Marketing Agreement, dated February 16, 2021, by and between EarlyBirdCapital, Inc. and Moringa Acquisition Corp
Contract Categories:
Business Operations
- Marketing Agreements
EX-10.1(1) 5 ea021197601ex10-1i_silexion.htm FINAL INVOICE ISSUED BY EARLYBIRDCAPITAL, INC. TO MORINGA ACQUISITION CORP UNDER THE BUSINESS COMBINATION MARKETING AGREEMENT, DATED FEBRUARY 16, 2021, BY AND BETWEEN EARLYBIRDCAPITAL, INC. AND MORINGA ACQUISITION CORP
Exhibit 10.1.1
EarlyBirdCapital, Inc.
366 Madison Avenue – 8th Floor
New York, NY 10017
Member FINRA SIPC
| Telephone: (212) 661-0200 | Facsimile: (212) 661-4936 |
INVOICE
| DATE: | 8/11/2024 |
| TO: | Moringa Acquisition Corp 250 Park Avenue, 7th Floor New York, NY, 10017 |
| Attention: | Ilan Levin Chairman and Chief Executive Officer |
For services rendered in connection with Moringa’s business combination with Silexion Therapeutics Ltd., please remit the amount set forth below:
| Cash portion of BCMA payable at closing | $ | 350,000 | ||
| BCMA payable in Convertible Promissory Note | 1,250,000 | |||
| Total | $ | 1,600,000 |
PAYMENT INSTRUCTIONS
Please send payment via wire transfer to:
Citibank N.A.
ABA Routing Number: [__________]
For the account of: EarlyBirdCapital, Inc.
Account Number: [_________]
